EGenesis
A gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues, and cells to address the global organ crisis. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD1.2—1.8b (Dealroom.co estimates Sep 2024.)
Cambridge Massachusetts (HQ)
Authorizing premium user...